Furthermore, OTUD6B facilitated tumor progression in many cancers, including lung adenocarcinoma, laryngeal squamous cell carcinoma, triple-negative breast cancer, and cholangiocarcinoma [10, 21–23]. Here, OTUD6B is linked to laryngeal squamous cell carcinoma.